0.0002
+0.0002
(0.00%)
As of December 27 at 3:00:00 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Sep 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.13 | -0.12 | -0.5 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Sep 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 6/30/2022 | 9/30/2022 | 12/31/2022 | 3/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.14 | -0.12 | -0.11 |
| EPS Actual | -0.13 | -0.12 | -0.11 | -0.12 |
| Difference | 0.01 | 0.02 | 0.01 | -0.01 |
| Surprise % | 10.34% | 11.11% | 8.33% | -9.09% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Sep 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2023) | Next Qtr. (Sep 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INFIQ | -- | -- | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Downgrade | Piper Sandler: Overweight to Neutral | 2/24/2023 |
| Downgrade | B. Riley Securities: Buy to Neutral | 11/16/2022 |
| Maintains | Piper Sandler: Overweight | 5/23/2022 |
| Maintains | Truist Securities: Buy | 3/31/2022 |
| Maintains | Piper Sandler: Overweight | 3/30/2022 |
| Initiated | HC Wainwright & Co.: Buy | 10/18/2021 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
20.66
-8.01%
ALRN Rein Therapeutics Inc.
2.1100
+9.33%
CYBN.NE Cybin Inc.
12.73
-0.94%
CDXS Codexis, Inc.
4.4850
+2.16%
ENZC Enzolytics, Inc.
0.0010
0.00%
ZVRA Zevra Therapeutics, Inc.
8.07
-0.55%
ACXP Acurx Pharmaceuticals, Inc.
0.7040
-12.89%
XERS Xeris Biopharma Holdings, Inc.
3.2500
-4.41%
CTMX CytomX Therapeutics, Inc.
0.8806
+0.06%
VRAX Virax Biolabs Group Limited
2.3800
-1.66%